ABBOTT DIAGNOSTICS TECHNOLOGIES AS: årsregnskap 2023 vs 2022
Grew 31% on revenue, weaker earnings
registry 2024-08-01; journal 2024 694223
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for ABBOTT DIAGNOSTICS TECHNOLOGIES AS. Revenue 1.05bn NOK → 1.38bn NOK (+31.3%). Net result +114.43m NOK → +62.28m NOK. Equity 2.36bn NOK → 1.26bn NOK.
On the constructive side: revenue rose; cash rose; current ratio back above 1×. Pressures included: operating result weakened; net result weakened; equity eroded.
Also worth watching: paid-in equity reduced; payroll increased; cogs moved. All figures are taken from the published annual accounts for ABBOTT DIAGNOSTICS TECHNOLOGIES AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 1.05bn NOK to 1.38bn NOK (+31.3% YoY). Calculated
-
↑
Cash rose
Bank deposits 9.74m NOK → 10.86m NOK (+11.5% YoY). Calculated
-
↑
Current ratio back above 1×
Current ratio 0.97× → 1.47×. Calculated
What deteriorated
-
↓
Operating result weakened
Operating result +87.22m NOK → -6.50m NOK (op. margin 8.3% → -0.5%). Calculated
-
↓
Net result weakened
Net result +114.43m NOK → +62.28m NOK (net margin 10.9% → 4.5%). Calculated
-
↓
Equity eroded
Book equity 2.36bn NOK → 1.26bn NOK (equity ratio 76.3% → 79.2%). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 1.84bn NOK → 1.20bn NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Payroll increased
Salary cost 4.15bn NOK → 4.17bn NOK (395% → 302% of revenue). Calculated
-
·
COGS moved
COGS / varekostnad 397.34m NOK → 505.88m NOK (+27.3% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 2.51bn NOK → 919.78m NOK. Reported fact
-
·
Headcount (årsverk) changed
Reported FTEs 259 → 302. Reported fact